BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24343217)

  • 1. Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes.
    Stavropoulos PG; Papafragkaki DK; Avgerinou G; Papafragkakis H; Katsavou A; Katsambas AD
    Cutis; 2013 Nov; 92(5):E1-4. PubMed ID: 24343217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Necrolytic migratory erythema revealing glucagonoma syndrome].
    Maouni S; Elanzi W; Sqalli A; Elmeknassi I; Meziane M; Benzekri L; Hassam B; Senouci K
    Ann Dermatol Venereol; 2019 May; 146(5):419-421. PubMed ID: 30910336
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed diagnosis of glucagonoma syndrome: a case report.
    Huo J; Liu P; Chen X; Wu J; An J; Ren J
    Int J Dermatol; 2016 Nov; 55(11):1272-1274. PubMed ID: 26679842
    [No Abstract]   [Full Text] [Related]  

  • 4. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
    Jiménez-Gallo D; Ossorio-García L; de la Varga-Martínez R; Arjona-Aguilera C; Linares-Barrios M
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508546
    [No Abstract]   [Full Text] [Related]  

  • 5. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation.
    Zhu WF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):598-600. PubMed ID: 34544669
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagonoma with necrolytic migratory erythema exhibiting responsiveness to subcutaneous octreotide injections.
    Lo CH; Ho CL; Shih YL
    QJM; 2014 Feb; 107(2):157-8. PubMed ID: 23389434
    [No Abstract]   [Full Text] [Related]  

  • 8. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
    Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
    Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
    Boujan N; Géraud C
    Lancet; 2020 Mar; 395(10228):985. PubMed ID: 32199485
    [No Abstract]   [Full Text] [Related]  

  • 10. [Necrolytic migratory erythema in a patient with a glucagonoma].
    Demirbas M; Prens B
    Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagonoma-related necrolytic migratory erythema.
    Bosch-Amate X; Riera-Monroig J; Iranzo Fernández P
    Med Clin (Barc); 2020 Nov; 155(9):418-419. PubMed ID: 31515063
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrolytic migratory erythema with recalcitrant dermatitis as the only presenting symptom.
    Garner R; Ahern K; Poligone B
    Cutis; 2016 Jun; 97(6):E6-7. PubMed ID: 27416097
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant glucagonoma: an uncommon cause of new onset diabetes].
    Guerrero Vázquez R; Oliva Rodríguez R; Cuenca Cuenca JI; Sánchez Alberdi F; Navarro González E
    Endocrinol Nutr; 2011 Apr; 58(4):199-201. PubMed ID: 21334267
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic glucagonoma with pancreatic calcification.
    Gupta RA; Udwadia FE; Agrawal P; Doctor N
    Pancreatology; 2013; 13(3):327-9. PubMed ID: 23719610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrolytic Migratory Erythema Associated with a Glucagonoma.
    Banerjee A; Shah SR
    N Engl J Med; 2020 Aug; 383(6):e39. PubMed ID: 32757527
    [No Abstract]   [Full Text] [Related]  

  • 18. Necrolytic migratory erythema associated with alteration from predominantly gastrin-secreting to predominantly glucagon-secreting pancreatic neuroendocrine tumor.
    Kido-Nakahara M; Nakahara T; Miki M; Igarashi H; Ito T; Furue M
    Eur J Dermatol; 2014; 24(6):702-3. PubMed ID: 25333507
    [No Abstract]   [Full Text] [Related]  

  • 19. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
    Saavedra C; Lamarca A; Hubner RA
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.